NCT06487104

Brief Summary

The use of Heat and Moisture Exchangers (HMEs) and their positive impact on pulmonary health have been extensively studied in patients with head and neck cancer but have not been systematically explored in other patient populations breathing through a neck stoma. The objective of this clinical investigation is to compare the use of HMEs to the use of External Humidifiers (EHs) on pulmonary secretion management, their usability and safety, for humidifying inhaled air in patients that received a tracheostomy due to a neurological condition.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2025

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 5, 2024

Completed
3 months until next milestone

First Posted

Study publicly available on registry

July 5, 2024

Completed
7 months until next milestone

Study Start

First participant enrolled

February 5, 2025

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

December 1, 2025

Status Verified

November 1, 2025

Enrollment Period

1.2 years

First QC Date

April 5, 2024

Last Update Submit

November 28, 2025

Conditions

Keywords

Heat and Moisture ExchangersSecretion

Outcome Measures

Primary Outcomes (1)

  • Number of suctioning per day

    Times per day suctioning is required

    At Baseline, after 10 days, and every 10 days until discharge from hospital (on average after 3 weeks)

Secondary Outcomes (13)

  • Time needed for suctioning

    At Baseline, after 10 days, and every 10 days until discharge from hospital (on average after 3 weeks)

  • Quality of secretion

    At Baseline, after 10 days, and every 10 days until discharge from hospital (on average after 3 weeks)

  • Quality of Life by EQ-5D-5L

    At Baseline, after 10 days, and every 10 days until discharge from hospital (on average after 3 weeks)

  • Use of TrachPhone

    At Baseline, after 10 days, and every 10 days until discharge from hospital (on average after 3 weeks)

  • Patient preference

    Upon discharge from the hospital (on average after 3 weeks)

  • +8 more secondary outcomes

Study Arms (2)

Arm 1 - HME

EXPERIMENTAL

24/7 use of TrachPhone HME for the entirety of study

Device: TrachPhone HME

Arm 2 - EH

ACTIVE COMPARATOR

24/7 use of EH until first follow-up (T1), then 24/7 use of TrachPhone HME for the remainder of the study participation.

Device: TrachPhone HMEDevice: External Humidifier (Usual Care)

Interventions

Use of TrachPhone HME for humidification of inhaled air in tracheostomized patients. The TrachPhone HME is an HME specifically designed for tracheostomy patients.

Arm 1 - HMEArm 2 - EH

Usual care routines using an External Humidifier for humidification of inhaled air in tracheostomized patients.

Arm 2 - EH

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Tracheostomy patient outside critical care
  • Self-ventilating via a tracheostomy tube, independent of cuff status
  • years or older

You may not qualify if:

  • Patients with tidal volume beyond recommended range (50-1000 ml)
  • Dehydration
  • Very heavy/excessive secretion from the lungs and airways (requiring more frequently tracheal suction, more than hourly suctioning)
  • High oxygen need (FiO2 \> 0.4)
  • Acutely deteriorating patient

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Royal London Hospital, Barts Health NHS Trust

London, United Kingdom

Location

Study Officials

  • Amanda Thomas, Dr

    The Royal London Hospital, Barts Health NHS Trust

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Single-center, two-armed randomized controlled trial with a subsequent feasibility phase, transitioning control-group patients to investigational device arm
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 5, 2024

First Posted

July 5, 2024

Study Start

February 5, 2025

Primary Completion

April 1, 2026

Study Completion

April 1, 2026

Last Updated

December 1, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations